مورد إلكتروني

The Utility of Automated ASPECTS in Acute Ischemic Stroke for Intravenous Recombinant Tissue Plasminogen Activator (IV-rtPA) Therapy.

التفاصيل البيبلوغرافية
العنوان: The Utility of Automated ASPECTS in Acute Ischemic Stroke for Intravenous Recombinant Tissue Plasminogen Activator (IV-rtPA) Therapy.
المؤلفون: Shibata, Soichiro
المصدر: Neurology International; vol 14, iss 4; 2035-8385
بيانات النشر: eScholarship, University of California 2022-11-21
تفاصيل مُضافة: Shibata, Soichiro
Sakurai, Kenzo
Tachikawa, Keiji
Ko, Riyoko
Hino, Sakae
Fukano, Takayuki
Isahaya, Kenji
Haraguchi, Takafumi
Yamauchi, Junji
Tanabe, Kenichiro
Nagasaka, Misako
Hagiwara, Yuta
Shimizu, Takahiro
Akiyama, Hisanao
Kobayashi, Yasuyuki
Hasegawa, Yasuhiro
Yamano, Yoshihisa
نوع الوثيقة: Electronic Resource
مستخلص: PURPOSE: This study aimed to investigate the accuracy and clinical significance of an artificial intelligence (AI)-based automated Alberta Stroke Program Early Computed Tomography (ASPECT) scoring software of head CT for the indication of intravenous recombinant tissue plasminogen activator (rt-PA) therapy. METHODS: This study included two populations of acute ischemic stroke: one comprised patients who had undergone head CT within 48 h of presentation (Population #1, n = 448), while the other included patients within 4.5 h from onset (Population #2, n = 132). The primary endpoint was the concordance rate of ASPECTS of the neurologists and AI software against the benchmark score. The secondary endpoints were to validate the accuracy of the neurologist and AI software in assessing the ability to rule out extensive infarction (ASPECTS of 0-5) in population #2. RESULTS: The reading accuracy of AI software was comparable to that of the board-certified vascular neurologists. The detection rate of cardiogenic cerebral embolism was better than that of atherothrombotic cerebral infarction. By excluding extensive infarction, AI-software showed a higher specificity and equivalent sensitivity compared to those of experts. CONCLUSIONS: The AI software for ASPECTS showed convincing agreement with expert evaluation and would be supportive in determining the indications of intravenous rt-PA therapy.
مصطلحات الفهرس: ASPECTS, acute cerebral infarction, artificial intelligence, recombinant tissue plasminogen activator therapy, article
URL: https://escholarship.org/uc/item/56h8j9nhTest
https://escholarship.orgTest/
الإتاحة: Open access content. Open access content
public
ملاحظة: application/pdf
Neurology International vol 14, iss 4 2035-8385
أرقام أخرى: CDLER oai:escholarship.org:ark:/13030/qt56h8j9nh
qt56h8j9nh
https://escholarship.org/uc/item/56h8j9nhTest
https://escholarship.orgTest/
1401040686
المصدر المساهم: UC MASS DIGITIZATION
From OAIster®, provided by the OCLC Cooperative.
رقم الانضمام: edsoai.on1401040686
قاعدة البيانات: OAIster